title: Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome.
abstract: Diamond Blackfan anemia (DBA) and myelodysplastic syndrome (MDS) with isolated del(5q) are severe macrocytic anemias; although both are associated with impaired ribosome assembly, why the anemia occurs is not known. We cultured marrow cells from DBA (n = 3) and del(5q) MDS (n = 6) patients and determined how heme (a toxic chemical) and globin (a protein) are coordinated. We show that globin translation initiates slowly, whereas heme synthesis proceeds normally. This results in insufficient globin protein, excess heme and excess reactive oxygen species in early erythroid precursors, and CFU-E (colony-forming unit-erythroid)/proerythroblast cell death. The cells that can more rapidly and effectively export heme or can slow heme synthesis preferentially survive and appropriately mature. Consistent with these observations, treatment with 10 μM succinylacetone, a specific inhibitor of heme synthesis, improved the erythroid cell output of DBA and del(5q) MDS marrow cultures by 68 to 95% (P = 0.03 to 0.05), whereas the erythroid cell output of concurrent control marrow cultures decreased by 4 to 13%. Our studies demonstrate that erythropoiesis fails when heme exceeds globin. Our data further suggest that therapies that decrease heme synthesis (or facilitate heme export) could improve the red blood cell production of persons with DBA, del(5q) MDS, and perhaps other macrocytic anemias.
authors.affiliation: University of Washington, Seattle, WA 98195, USA.
authors.forename: Zhantao
authors.initials: Z
authors.lastname: Yang
authors.affiliation: University of Washington, Seattle, WA 98195, USA.
authors.forename: Siobán B
authors.initials: SB
authors.lastname: Keel
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. Seattle Children's Hospital, Seattle, WA 98105, USA.
authors.forename: Akiko
authors.initials: A
authors.lastname: Shimamura
authors.affiliation: University of Washington, Seattle, WA 98195, USA.
authors.forename: Li
authors.initials: L
authors.lastname: Liu
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
authors.forename: Aaron T
authors.initials: AT
authors.lastname: Gerds
authors.affiliation: Polyclinic, Seattle, WA 98104, USA.
authors.forename: Henry Y
authors.initials: HY
authors.lastname: Li
authors.affiliation: University of Washington, Seattle, WA 98195, USA.
authors.forename: Brent L
authors.initials: BL
authors.lastname: Wood
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
authors.forename: Bart L
authors.initials: BL
authors.lastname: Scott
authors.affiliation: University of Washington, Seattle, WA 98195, USA. janabk@uw.edu.
authors.forename: Janis L
authors.initials: JL
authors.lastname: Abkowitz
mesh_terms: D000328:Adult; D000740:Anemia / Q000378:metabolism*; D029503:Anemia, Diamond-Blackfan / Q000378:metabolism*; D000748:Anemia, Macrocytic / Q000378:metabolism*; D041905:Erythroid Cells / Q000378:metabolism; D004920:Erythropoiesis / Q000502:physiology; D005260:Female; D005434:Flow Cytometry; D005914:Globins / Q000378:metabolism*; D006418:Heme / Q000378:metabolism*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000378:metabolism*; D017382:Reactive Oxygen Species / Q000378:metabolism
chemical_list: D017382:Reactive Oxygen Species; D006418:Heme; D005914:Globins